Valuation cbdMD, Inc.

Stocks

Market Closed - NYSE 16:00:00 2026-09-28 EDT			5-day change	1st Jan Change
0.4635 ^USD	-0.96%		+2.98%	-65.67%

09-02	CbdMD, Inc. entered into a definitive asset purchase agreement to acquire Operating assets and brands of Twinlab Consolidation Corporation for $2.9 million.	CI
08-17	Maxim Group Downgrades cbdMD to Hold From Buy	MT

Data adjusted to current consolidation scope

Fiscal Period: September	2021	2022	2023	2024	2025	2026	2027
Market Cap ¹	120.2	13.63	2.958	1.804	10.78	5.244	-
Change	-	-88.66%	-78.3%	-39.01%	497.8%	-51.38%	-
Enterprise Value (EV)	93.93	13.63	2.958	1.804	10.78	5.244	5.244
Change	-	-85.49%	-78.3%	-39.01%	497.8%	-51.38%	0%
P/E	-4.43x	-0.18x	-0.08x	-0.26x	-1.11x	-1.4x	-2.44x
PBR	-	-	-	-	-	-	-
PEG	-	-0x	0x	0x	0x	0x	0.1x
Capitalization / Revenue	2.7x	-	0.12x	0.09x	0.56x	0.24x	0.18x
EV / Revenue	0x	-	0x	0x	0x	0.24x	0.18x
EV / EBITDA	-	-	-	-	-	-	-
EV / EBIT	-0x	-	-0x	-0x	-0x	-1.7x	-1.12x
EV / FCF	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-
EPS ²	-169.2	-446.4	-106.6	-14.32	-1.09	-0.33	-0.19
Distribution rate	-	-	-	-	-	-	-
Net sales ¹	44.48	-	24.16	19.48	19.19	21.92	28.6
EBITDA	-18.6	-	-	-	-	-	-
EBIT ¹	-19.62	-	-5.527	-1.592	-0.9098	-3.076	-4.662
Net income ¹	-25.95	-70.08	-26.94	-7.704	-2.041	-3.332	-4.946
Net Debt	-26.24	-	-	-	-	-	-
Reference price ²	748.8000	81.0360	8.2800	3.7600	1.2100	0.4635	0.4635
Nbr of stocks (in thousands)	160	168	357	480	8,913	11,205	-
Announcement Date	12/17/21	12/15/22	12/22/23	12/18/24	12/19/25	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CBDMD, INC.	-1.42x	-	-	-	5.24M
ELI LILLY AND COMPANY	33.65x	12.19x	24.78x	0.59%	1,055B
JOHNSON & JOHNSON	30.17x	6.71x	18.78x	1.98%	654B
ABBVIE INC.	33.43x	7.82x	16.17x	2.59%	467B
ROCHE HOLDING AG	19.59x	4.78x	11.84x	2.78%	348B
NOVARTIS AG	20.4x	5.31x	13.17x	3.01%	275B
ASTRAZENECA PLC	21.19x	4.39x	12.5x	2.01%	258B
AMGEN INC.	26.19x	6.82x	12.15x	2.43%	224B
GILEAD SCIENCES, INC.	-45.65x	6.64x	25.94x	2.18%	187B
NOVO NORDISK A/S	11.33x	4.13x	8.58x	4.44%	171B
Average	14.89x	6.53x	15.99x	2.45%	363.84B
Weighted average by Cap.	24.18x	7.87x	18.13x	1.96%